{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:45:51Z","timestamp":1791006351467,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,7,11]],"date-time":"2007-07-11T00:00:00Z","timestamp":1184112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1038\/sj.npp.1301502","type":"journal-article","created":{"date-parts":[[2007,7,11]],"date-time":"2007-07-11T08:30:12Z","timestamp":1184142612000},"page":"1441-1452","source":"Crossref","is-referenced-by-count":68,"title":["Long-Term Methamphetamine Administration in the Vervet Monkey Models Aspects of a Human Exposure: Brain Neurotoxicity and Behavioral Profiles"],"prefix":"10.1038","volume":"33","author":[{"given":"William P","family":"Melega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"La\u0107an","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baldwin M","family":"Way","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grenvill","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur K","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn A","family":"Fairbanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,11]]},"reference":[{"key":"BF1301502_CR1","first-page":"845","volume-title":"Handbook of Neurotoxicology","author":"JF Bowyer","year":"1995","unstructured":"Bowyer JF, Holson RR (1995). Methamphetamine and amphetamine neurotoxicity. In: Chang LW, Dyers RS (eds). Handbook of Neurotoxicology. Marcel Dekker: New York. pp 845\u2013870."},{"key":"BF1301502_CR2","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1096\/fj.03-0073rev","volume":"17","author":"JL Cadet","year":"2003","unstructured":"Cadet JL, Jayanthi S, Deng X (2003). Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J 17: 1775\u20131788.","journal-title":"FASEB J"},{"key":"BF1301502_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0893-133X(98)00050-5","volume":"20","author":"SA Castner","year":"1999","unstructured":"Castner SA, Goldman-Rakic PS (1999). Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology 20: 10\u201328.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301502_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E","volume":"39","author":"AK Cho","year":"2001","unstructured":"Cho AK, Melega WP, Kuczenski R, Segal DS (2001). Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39: 161\u2013166.","journal-title":"Synapse"},{"key":"BF1301502_CR5","first-page":"717","volume":"21","author":"CE Cook","year":"1993","unstructured":"Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM et al (1993). Pharmacokinetics of methamphetamine self-administered to human subjects by smoking hydrochloride. Drug Metab Dispos 21: 717\u2013723.","journal-title":"Drug Metab Dispos"},{"key":"BF1301502_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0740-5472(03)00028-X","volume":"24","author":"M Cretzmeyer","year":"2003","unstructured":"Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA (2003). Treatment of methamphetamine abuse: research findings and clinical directions. J Subst Abuse Treat 24: 267\u2013277.","journal-title":"J Subst Abuse Treat"},{"key":"BF1301502_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0173(01)00054-6","volume":"36","author":"C Davidson","year":"2001","unstructured":"Davidson C, Gow AJ, Lee TH, Ellinwood EH (2001). Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Rev 36: 1\u201322.","journal-title":"Brain Res Rev"},{"key":"BF1301502_CR8","first-page":"593","volume":"201","author":"MW Fischman","year":"1977","unstructured":"Fischman MW, Schuster CR (1977). Long-term behavioral changes in the rhesus monkey after multiple daily injections of D-methylamphetamine. J Pharmacol Exp Ther 201: 593\u2013605.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1301502_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0014-2999(97)01152-7","volume":"334","author":"K Frey","year":"1997","unstructured":"Frey K, Kilbourn M, Robinson T (1997). Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur J Pharmacol 334: 273\u2013279.","journal-title":"Eur J Pharmacol"},{"key":"BF1301502_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0031-9384(93)90159-D","volume":"53","author":"DA Gust","year":"1993","unstructured":"Gust DA, Gordon TP, Hambright MK (1993). Response to removal from and return to a social group in adult male rhesus monkeys. Physiol Behav 53: 599\u2013602.","journal-title":"Physiol Behav"},{"key":"BF1301502_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s002210000386","volume":"133","author":"DC Harvey","year":"2000","unstructured":"Harvey DC, Lacan G, Melega WP (2000). Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure. Exp Brain Res 133: 349\u2013358.","journal-title":"Exp Brain Res"},{"key":"BF1301502_CR12","first-page":"92","volume":"60","author":"A Huff","year":"2003","unstructured":"Huff A, Jorgensen M, Melega WP, Fairbanks LA (2003). The effects of ketamine on vervet monkeys. Am J Primatology 60: 92\u201393.","journal-title":"Am J Primatology"},{"key":"BF1301502_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00213-006-0330-6","volume":"185","author":"CE Johanson","year":"2006","unstructured":"Johanson CE, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J et al (2006). Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology (Berl) 185: 327\u2013338.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1301502_CR14","first-page":"247","volume-title":"Substance Abuse: A Comprehensive Textbook","author":"G King","year":"1992","unstructured":"King G, Ellinwood Jr E (1992). Amphetamines and other stimulants. In: Lowinson J, Ruiz P, Millman R and Langrod J (eds). Substance Abuse: A Comprehensive Textbook. Williams & Wilkins: Baltimore. pp 247\u2013270."},{"key":"BF1301502_CR15","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","volume":"15","author":"R Kuczenski","year":"1995","unstructured":"Kuczenski R, Segal D, Cho A, Melega W (1995). Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15: 1308\u20131317.","journal-title":"J Neurosci"},{"key":"BF1301502_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4065\/81.1.77","volume":"81","author":"TW Lineberry","year":"2006","unstructured":"Lineberry TW, Bostwick JM (2006). Methamphetamine abuse: a perfect storm of complications. Mayo Clin Proc 81: 77\u201384.","journal-title":"Mayo Clin Proc"},{"key":"BF1301502_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11920-006-0035-x","volume":"8","author":"W Ling","year":"2006","unstructured":"Ling W, Rawson R, Shoptaw S (2006). Management of methamphetamine abuse and dependence. Curr Psychiatry Rep 8: 345\u2013354.","journal-title":"Curr Psychiatry Rep"},{"key":"BF1301502_CR18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1520\/JFS16085J","volume":"43","author":"BK Logan","year":"1998","unstructured":"Logan BK, Fligner CL, Haddix T (1998). Cause and manner of death in fatalities involving methamphetamine. J Forensic Sci 43: 28\u201334.","journal-title":"J Forensic Sci"},{"key":"BF1301502_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajp.10075","volume":"60","author":"C Lutz","year":"2003","unstructured":"Lutz C, Well A, Novak M (2003). Stereotypic and self-injurious behavior in rhesus macaques: a survey and retrospective analysis of environment and early experience. Am J Primatol 60: 1\u201315.","journal-title":"Am J Primatol"},{"key":"BF1301502_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/schbul\/18.1.107","volume":"18","author":"Y Machiyama","year":"1992","unstructured":"Machiyama Y (1992). Chronic methamphetamine intoxication model of schizophrenia in animals. Schizophr Bull 18: 107\u2013113.","journal-title":"Schizophr Bull"},{"key":"BF1301502_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/sj.npp.1300575","volume":"30","author":"LJ Madden","year":"2005","unstructured":"Madden LJ, Flynn CT, Zandonatti MA, May M, Parsons LH, Katner SN et al (2005). Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities. Neuropsychopharmacology 30: 350\u2013359.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301502_CR22","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139168342","volume-title":"Measuring Behaviour: An Introductory Guide","author":"P Martin","year":"1993","unstructured":"Martin P, Bateson P (1993). Measuring Behaviour: An Introductory Guide. Cambridge University Press: Cambridge."},{"key":"BF1301502_CR23","doi-asserted-by":"publisher","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","volume":"18","author":"UD McCann","year":"1998","unstructured":"McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA (1998). Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [C-11]WIN-35, 428. J Neurosci 18: 8417\u20138422.","journal-title":"J Neurosci"},{"key":"BF1301502_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/syn.20365","volume":"61","author":"WP Melega","year":"2007","unstructured":"Melega WP, Cho AK, Harvey D, Lacan G (2007). Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse 61: 216\u2013220.","journal-title":"Synapse"},{"key":"BF1301502_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0006-8993(97)00548-9","volume":"766","author":"WP Melega","year":"1997","unstructured":"Melega WP, Raleigh MJ, Stout DB, Lacan G, Huang SC, Phelps ME (1997). Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res 766: 113\u2013120.","journal-title":"Brain Res"},{"key":"BF1301502_CR26","first-page":"90","volume":"274","author":"WP Melega","year":"1995","unstructured":"Melega WP, Williams AE, Schmitz D, Stefano ED, Cho AK (1995). Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 274: 90\u201396.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1301502_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/10673220591003605","volume":"13","author":"CW Meredith","year":"2005","unstructured":"Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ (2005). Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 13: 141\u2013154.","journal-title":"Harv Rev Psychiatry"},{"key":"BF1301502_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00427259","volume":"81","author":"KA Miczek","year":"1983","unstructured":"Miczek KA, Gold LH (1983). -amphetamine in squirrel monkeys of different social status: effects on social and agonistic behavior, locomotion, and stereotypies. Psychopharmacology 81: 183\u2013190.","journal-title":"Psychopharmacology"},{"key":"BF1301502_CR29","first-page":"132","volume":"40","author":"T Miyazaki","year":"1986","unstructured":"Miyazaki T (1986). Relation between methamphetamine and amphetamine concentrations in the blood and symptoms in methamphetamine abusers. Nihon Hoigaku Zasshi 40: 132\u2013139.","journal-title":"Nihon Hoigaku Zasshi"},{"key":"BF1301502_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/syn.20320","volume":"60","author":"ML O'Neil","year":"2006","unstructured":"O'Neil ML, Kuczenski R, Segal DS, Cho AK, Lacan G, Melega WP (2006). Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge. Synapse 60: 465\u2013473.","journal-title":"Synapse"},{"key":"BF1301502_CR31","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/sj.npp.1300247","volume":"28","author":"DS Segal","year":"2003","unstructured":"Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK (2003). Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharmacology 28: 1730\u20131740.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301502_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00213-005-2188-4","volume":"180","author":"DS Segal","year":"2005","unstructured":"Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK (2005). Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization. Psychopharmacology (Berl) 180: 501\u2013512.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1301502_CR33","first-page":"100","volume":"62","author":"LS Seiden","year":"1985","unstructured":"Seiden LS (1985). Methamphetamine: toxicity to dopaminergic neurons. NIDA Res Monogr 62: 100\u2013116.","journal-title":"NIDA Res Monogr"},{"key":"BF1301502_CR34","first-page":"251","volume":"163","author":"LS Seiden","year":"1996","unstructured":"Seiden LS, Sabol KE (1996). Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res Monogr 163: 251\u2013276.","journal-title":"NIDA Res Monogr"},{"key":"BF1301502_CR35","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1176\/appi.ajp.158.8.1206","volume":"158","author":"Y Sekine","year":"2001","unstructured":"Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H et al (2001). Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 158: 1206\u20131214.","journal-title":"Am J Psychiatry"},{"key":"BF1301502_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1300\/J069v21n01_04","volume":"21","author":"SL Simon","year":"2002","unstructured":"Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson R et al (2002). A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 21: 35\u201344.","journal-title":"J Addict Dis"},{"key":"BF1301502_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","volume":"158","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D et al (2001). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158: 377\u2013382.","journal-title":"Am J Psychiatry"},{"key":"BF1301502_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1176\/appi.ajp.161.2.242","volume":"161","author":"GJ Wang","year":"2004","unstructured":"Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R et al (2004). Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 161: 242\u2013248.","journal-title":"Am J Psychiatry"},{"key":"BF1301502_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nm0696-699","volume":"2","author":"JM Wilson","year":"1996","unstructured":"Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM et al (1996). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Medicine 2: 699\u2013703.","journal-title":"Nature Medicine"},{"key":"BF1301502_CR40","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/sj.mp.4000760","volume":"5","author":"JN Worsley","year":"2000","unstructured":"Worsley JN, Moszczynska A, Falardeau P, Kalasinsky KS, Schmunk G, Guttman M et al (2000). Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Mol Psychiatry 5: 664\u2013672.","journal-title":"Mol Psychiatry"},{"key":"BF1301502_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/ADA-100101843","volume":"25","author":"WA Zule","year":"1999","unstructured":"Zule WA, Desmond DP (1999). An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. Am J Drug Alcohol Abuse 25: 1\u201323.","journal-title":"Am J Drug Alcohol Abuse"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1301502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301502","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:27:46Z","timestamp":1737246466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1301502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["BF1301502"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1301502","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,11]]}}}